See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: May 30, 2006

Psoriasis and Psoriatic Disorders Diabetes - Type 2 Genital Herpes

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Psoriasis and Psoriatic Disorders

This study will evaluate the use of Enbrel (etanercept) to treat psoriasis for a period of up to one year. Candidates 18 or older with moderate-to-severe plaque psoriasis who are able to start Enbrel therapy as prescribed may be eligible. People with skin conditions other than psoriasis that would interfere with study evaluations, or people taking Remicade (infliximab), Humira (adalimumab) or Amevive (alefacept) will not qualify. Research sites are located throughout Canada.

More information

Please see http://www.centerwatch.com/patient/studies/cat126.html.

-----

Diabetes - Type 2

This is a research study of an investigational medication for diabetes. If you are older than age 16, have been diagnosed with type 2 diabetes, and are currently taking a Sulfonylurea medication only (ie, glipizide, amaryl), you may qualify. Participants may receive at no cost study-related medication, lab testing, ECG's, and physical exams. The research site is in Walnut Creek, Calif.

More information

Please see http://www.centerwatch.com/patient/studies/cat603.html.

-----

Genital Herpes

This is a clinical study of an approved medication for the treatment of gastroesophageal disease (GERD). Volunteers at least 18 who have a history of GERD-related symptoms for the past six months and have had heartburn for at least four days during the week prior to inclusion in the study may qualify. The research site is in Huntsville, Ala.

More information

Please see http://www.centerwatch.com/patient/studies/cat173.html.

-----

Copyright 2006 CenterWatch. All rights reserved.

Consumer News
undefined
undefinedundefined